BRIEF-Bristol-Myers Squibb signs exclusive agreement with Bavarian Nordic for PROSTVAC
March 04, 2015 at 01:39 AM EST
* Bristol-Myers Squibb signs exclusive agreement with Bavarian Nordic for PROSTVAC, a prostate-specific antigen-targeting cancer immunotherapy